Transgenic mouse models have shown that PTEN haploinsufficiency or heterozygosity in mouse prostate epithelium can cause prostate lesions, whereas homozygous PTEN deletion causes prostate carcinoma [20,23,94]. The gene discussed is PTEN; the disease is prostate carcinoma.